analyst
MY
NASDAQ · MYGN
Myriad Genetics, Inc.
Healthcare · Medical - Diagnostics & Research
$4.01
Down-$0.08 (-1.87%)
Updated Sep 22, 2026, 4:00 PM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 680.86M
- P/E ratio
- -1.71
- Dividend yield
- 0.00%
- 52-week range
- $2.74 – $8.59
- Volume
- 1.89M
- Avg. volume
- 1.22M
Price performance
MYGN price history
1M range · 20 trading sessions · Daily adjusted prices
MYGN closed at $4.01 after 20 trading sessions, up 31.48% for the selected period.
- Last close
- $4.01
- Period change
- +31.48%
- Period low
- $3.05
- Period high
- $4.14
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 21, 2026 | $3.93 | $4.035 | $3.87 | $4.01 | 1.89M |
| Sep 18, 2026 | $4.15 | $4.17 | $3.86 | $3.89 | 3.51M |
| Sep 17, 2026 | $3.885 | $4.17 | $3.75 | $4.14 | 2.83M |
| Sep 16, 2026 | $3.75 | $4.085 | $3.75 | $3.86 | 2.05M |
| Sep 15, 2026 | $3.795 | $3.98 | $3.695 | $3.88 | 4.68M |
| Sep 14, 2026 | $3.43 | $3.82 | $3.42 | $3.79 | 2.6M |
| Sep 11, 2026 | $3.37 | $3.425 | $3.195 | $3.42 | 2.55M |
| Sep 10, 2026 | $3.14 | $3.365 | $3.06 | $3.36 | 3.94M |
| Sep 9, 2026 | $3.11 | $3.215 | $3.085 | $3.19 | 967K |
| Sep 8, 2026 | $3.18 | $3.215 | $3.105 | $3.18 | 1.19M |
| Sep 4, 2026 | $3.19 | $3.20 | $3.15 | $3.19 | 806.16K |
| Sep 3, 2026 | $3.25 | $3.32 | $3.16 | $3.23 | 959.06K |
| Sep 2, 2026 | $3.16 | $3.35 | $3.16 | $3.23 | 1.35M |
| Sep 1, 2026 | $2.95 | $3.215 | $2.92 | $3.18 | 3.03M |
| Aug 31, 2026 | $3.15 | $3.26 | $3.04 | $3.22 | 1.54M |
| Aug 28, 2026 | $3.15 | $3.20 | $3.07 | $3.16 | 1.43M |
| Aug 27, 2026 | $3.11 | $3.2699 | $3.09 | $3.18 | 1.28M |
| Aug 26, 2026 | $3.18 | $3.19 | $3.085 | $3.12 | 1.29M |
| Aug 25, 2026 | $3.06 | $3.21 | $3.01 | $3.19 | 1.76M |
| Aug 24, 2026 | $3.20 | $3.20 | $3.00 | $3.05 | 1.35M |
Latest MYGN news
The latest Smart Investors Daily articles mentioning MYGN.
Stock researchResearch & News · SEC Filings
Loading stock research…